CN104389155B - 一种医用材料及制备方法 - Google Patents
一种医用材料及制备方法 Download PDFInfo
- Publication number
- CN104389155B CN104389155B CN201410787569.7A CN201410787569A CN104389155B CN 104389155 B CN104389155 B CN 104389155B CN 201410787569 A CN201410787569 A CN 201410787569A CN 104389155 B CN104389155 B CN 104389155B
- Authority
- CN
- China
- Prior art keywords
- add
- rinsing
- water
- dry
- reactant liquor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 55
- 239000012567 medical material Substances 0.000 title claims abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 335
- 238000005406 washing Methods 0.000 claims abstract description 174
- 238000004140 cleaning Methods 0.000 claims abstract description 112
- 238000000034 method Methods 0.000 claims abstract description 94
- 230000008569 process Effects 0.000 claims abstract description 84
- 230000001954 sterilising effect Effects 0.000 claims abstract description 74
- 238000001035 drying Methods 0.000 claims abstract description 73
- 229920002678 cellulose Polymers 0.000 claims abstract description 54
- 239000001913 cellulose Substances 0.000 claims abstract description 54
- 238000004806 packaging method and process Methods 0.000 claims abstract description 52
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 39
- 239000002994 raw material Substances 0.000 claims abstract description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 329
- 239000004744 fabric Substances 0.000 claims description 241
- 239000000463 material Substances 0.000 claims description 233
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 152
- 239000000376 reactant Substances 0.000 claims description 140
- 239000008213 purified water Substances 0.000 claims description 112
- 239000007788 liquid Substances 0.000 claims description 106
- 238000003756 stirring Methods 0.000 claims description 90
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 86
- 238000009835 boiling Methods 0.000 claims description 76
- 239000000284 extract Substances 0.000 claims description 63
- 229910001220 stainless steel Inorganic materials 0.000 claims description 63
- 239000010935 stainless steel Substances 0.000 claims description 63
- 238000005956 quaternization reaction Methods 0.000 claims description 55
- 238000006266 etherification reaction Methods 0.000 claims description 50
- FDRCDNZGSXJAFP-UHFFFAOYSA-M sodium chloroacetate Chemical compound [Na+].[O-]C(=O)CCl FDRCDNZGSXJAFP-UHFFFAOYSA-M 0.000 claims description 45
- 229920000297 Rayon Polymers 0.000 claims description 43
- 238000005516 engineering process Methods 0.000 claims description 42
- 239000002964 rayon Substances 0.000 claims description 42
- 238000012360 testing method Methods 0.000 claims description 38
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 34
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 claims description 34
- 102000011759 adducin Human genes 0.000 claims description 32
- 108010076723 adducin Proteins 0.000 claims description 32
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 26
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 claims description 26
- 238000010411 cooking Methods 0.000 claims description 25
- 230000002439 hemostatic effect Effects 0.000 claims description 25
- 238000007654 immersion Methods 0.000 claims description 22
- 238000003556 assay Methods 0.000 claims description 18
- 239000003795 chemical substances by application Substances 0.000 claims description 17
- 230000007935 neutral effect Effects 0.000 claims description 17
- 238000010926 purge Methods 0.000 claims description 16
- 238000005070 sampling Methods 0.000 claims description 16
- 239000000758 substrate Substances 0.000 claims description 16
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 15
- 230000018044 dehydration Effects 0.000 claims description 15
- 238000006297 dehydration reaction Methods 0.000 claims description 15
- 239000003599 detergent Substances 0.000 claims description 15
- 239000011435 rock Substances 0.000 claims description 14
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 claims description 12
- 229940005657 pyrophosphoric acid Drugs 0.000 claims description 12
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 11
- RCEAADKTGXTDOA-UHFFFAOYSA-N OS(O)(=O)=O.CCCCCCCCCCCC[Na] Chemical compound OS(O)(=O)=O.CCCCCCCCCCCC[Na] RCEAADKTGXTDOA-UHFFFAOYSA-N 0.000 claims description 10
- 239000002250 absorbent Substances 0.000 claims description 6
- 230000002745 absorbent Effects 0.000 claims description 6
- 239000004627 regenerated cellulose Substances 0.000 abstract description 22
- 238000005213 imbibition Methods 0.000 abstract description 3
- 235000019441 ethanol Nutrition 0.000 description 145
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 124
- 239000000243 solution Substances 0.000 description 82
- 235000011121 sodium hydroxide Nutrition 0.000 description 45
- 239000000047 product Substances 0.000 description 43
- 238000006243 chemical reaction Methods 0.000 description 39
- 230000000694 effects Effects 0.000 description 37
- 238000007254 oxidation reaction Methods 0.000 description 27
- 230000003647 oxidation Effects 0.000 description 22
- 229920000742 Cotton Polymers 0.000 description 21
- 206010013786 Dry skin Diseases 0.000 description 15
- 206010052428 Wound Diseases 0.000 description 15
- 208000027418 Wounds and injury Diseases 0.000 description 15
- 229910000831 Steel Inorganic materials 0.000 description 14
- 238000010521 absorption reaction Methods 0.000 description 14
- 210000003298 dental enamel Anatomy 0.000 description 14
- 230000023597 hemostasis Effects 0.000 description 14
- KMUONIBRACKNSN-UHFFFAOYSA-N potassium dichromate Chemical compound [K+].[K+].[O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O KMUONIBRACKNSN-UHFFFAOYSA-N 0.000 description 14
- 239000010959 steel Substances 0.000 description 14
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 13
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 12
- 238000013461 design Methods 0.000 description 12
- 230000007306 turnover Effects 0.000 description 12
- 235000011007 phosphoric acid Nutrition 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 8
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 8
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 8
- 239000000835 fiber Substances 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 239000011734 sodium Substances 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- 208000032843 Hemorrhage Diseases 0.000 description 7
- 239000003513 alkali Substances 0.000 description 7
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 7
- 238000006467 substitution reaction Methods 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- 239000001768 carboxy methyl cellulose Substances 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 238000002791 soaking Methods 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 239000002253 acid Chemical group 0.000 description 5
- 238000002425 crystallisation Methods 0.000 description 5
- 230000008025 crystallization Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 159000000000 sodium salts Chemical class 0.000 description 4
- 238000004448 titration Methods 0.000 description 4
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 3
- 208000031737 Tissue Adhesions Diseases 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 3
- 229920002521 macromolecule Polymers 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- SJRXVLUZMMDCNG-UHFFFAOYSA-N Gossypin Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C2=C1OC(C=1C=C(O)C(O)=CC=1)=C(O)C2=O SJRXVLUZMMDCNG-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000002847 Surgical Wound Diseases 0.000 description 2
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 239000012670 alkaline solution Substances 0.000 description 2
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 229920003086 cellulose ether Polymers 0.000 description 2
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- -1 environment Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- SJRXVLUZMMDCNG-KKPQBLLMSA-N gossypin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(O)C=C(O)C2=C1OC(C=1C=C(O)C(O)=CC=1)=C(O)C2=O SJRXVLUZMMDCNG-KKPQBLLMSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000000025 haemostatic effect Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000003317 industrial substance Substances 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 description 2
- 229960001907 nitrofurazone Drugs 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 239000011265 semifinished product Substances 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- NLVXSWCKKBEXTG-UHFFFAOYSA-N vinylsulfonic acid Chemical compound OS(=O)(=O)C=C NLVXSWCKKBEXTG-UHFFFAOYSA-N 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- QLOKJRIVRGCVIM-UHFFFAOYSA-N 1-[(4-methylsulfanylphenyl)methyl]piperazine Chemical group C1=CC(SC)=CC=C1CN1CCNCC1 QLOKJRIVRGCVIM-UHFFFAOYSA-N 0.000 description 1
- 0 C*CCOCC(C(C(*)C1*)N=O)OC1OC(C(CN=O)*C(*C(C(C*)OC(C1O)C(*)(*)*C(C(C*C)*C(*C(*)(C(*)C*)C(*)C(*)C(*)C(N)=O)C2N)C2O)C1O)C1O)C1O Chemical compound C*CCOCC(C(C(*)C1*)N=O)OC1OC(C(CN=O)*C(*C(C(C*)OC(C1O)C(*)(*)*C(C(C*C)*C(*C(*)(C(*)C*)C(*)C(*)C(*)C(N)=O)C2N)C2O)C1O)C1O)C1O 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 125000003535 D-glucopyranosyl group Chemical group [H]OC([H])([H])[C@@]1([H])OC([H])(*)[C@]([H])(O[H])[C@@]([H])(O[H])[C@]1([H])O[H] 0.000 description 1
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000208125 Nicotiana Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical class O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010051077 Post procedural haemorrhage Diseases 0.000 description 1
- 208000037486 Postoperative Hemorrhage Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010039203 Road traffic accident Diseases 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010042566 Superinfection Diseases 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 206010070995 Vascular compression Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 150000001299 aldehydes Chemical group 0.000 description 1
- 230000003113 alkalizing effect Effects 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- SOIFLUNRINLCBN-UHFFFAOYSA-N ammonium thiocyanate Chemical compound [NH4+].[S-]C#N SOIFLUNRINLCBN-UHFFFAOYSA-N 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127090 anticoagulant agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000011013 aquamarine Substances 0.000 description 1
- 238000004380 ashing Methods 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 229940106681 chloroacetic acid Drugs 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- CDMADVZSLOHIFP-UHFFFAOYSA-N disodium;3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane;decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].O1B([O-])OB2OB([O-])OB1O2 CDMADVZSLOHIFP-UHFFFAOYSA-N 0.000 description 1
- UZUODNWWWUQRIR-UHFFFAOYSA-L disodium;3-aminonaphthalene-1,5-disulfonate Chemical compound [Na+].[Na+].C1=CC=C(S([O-])(=O)=O)C2=CC(N)=CC(S([O-])(=O)=O)=C21 UZUODNWWWUQRIR-UHFFFAOYSA-L 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000007380 fibre production Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000003197 gene knockdown Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008233 hard water Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 150000002576 ketones Chemical group 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- YLGXILFCIXHCMC-JHGZEJCSSA-N methyl cellulose Chemical compound COC1C(OC)C(OC)C(COC)O[C@H]1O[C@H]1C(OC)C(OC)C(OC)OC1COC YLGXILFCIXHCMC-JHGZEJCSSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- GDOPTJXRTPNYNR-UHFFFAOYSA-N methyl-cyclopentane Natural products CC1CCCC1 GDOPTJXRTPNYNR-UHFFFAOYSA-N 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 238000010525 oxidative degradation reaction Methods 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 150000004968 peroxymonosulfuric acids Chemical class 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000004076 pulp bleaching Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000008234 soft water Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 231100000456 subacute toxicity Toxicity 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000010148 water-pollination Effects 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410787569.7A CN104389155B (zh) | 2014-12-18 | 2014-12-18 | 一种医用材料及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410787569.7A CN104389155B (zh) | 2014-12-18 | 2014-12-18 | 一种医用材料及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104389155A CN104389155A (zh) | 2015-03-04 |
CN104389155B true CN104389155B (zh) | 2016-02-24 |
Family
ID=52607109
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410787569.7A Active CN104389155B (zh) | 2014-12-18 | 2014-12-18 | 一种医用材料及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104389155B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108367093A (zh) * | 2015-10-07 | 2018-08-03 | 先进生命科学公司 | 用于止血、组织屏障、创伤愈合和美容的生物相容性羧甲基纤维素基质(bcm) |
CN106038723A (zh) * | 2016-06-28 | 2016-10-26 | 郑胜 | 一种治疗骨性膝关节炎的中药凝胶膏及其制备方法 |
CN106421875B (zh) * | 2016-11-15 | 2019-08-27 | 广州迈普再生医学科技股份有限公司 | 可降解吸收的止血纤维材料及其制备方法和止血纤维制品 |
CN106866828B (zh) * | 2017-04-18 | 2019-02-05 | 傅兵 | 一种二次醚化生产阳离子纤维素纤维的方法 |
CN107382154A (zh) * | 2017-08-31 | 2017-11-24 | 安徽智博新材料科技有限公司 | 电容器内喇叭管用保温材料的制备方法及使用方法 |
WO2021136531A1 (zh) * | 2019-12-31 | 2021-07-08 | 广州迈普再生医学科技股份有限公司 | 纤维材料、纤维聚集体及其制备方法和用途 |
CN111320705A (zh) * | 2020-04-26 | 2020-06-23 | 山东洲星天然物提取智能设备有限公司 | 一种高黏纤维素醚的制备方法 |
CN114875571B (zh) * | 2022-06-07 | 2023-04-28 | 广州宇然膜丽无纺制品有限公司 | 一种高吸水高透明无纺布及其制备方法与应用 |
CN115522381A (zh) * | 2022-09-30 | 2022-12-27 | 湖南佰欧泰医药有限责任公司 | 一种亲水性纤维结构的制备工艺 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1269376A (zh) * | 2000-03-24 | 2000-10-11 | 大连永兴医用材料有限公司 | 用纤维素材料制备可溶性防粘连材料的方法及其产品 |
CN1286329A (zh) * | 1999-08-30 | 2001-03-07 | 北京纺织科学研究所 | 一种水溶性止血纤维素纤维及其制造方法 |
CN100398159C (zh) * | 2001-04-30 | 2008-07-02 | 北京纺织科学研究所 | 水溶性纤维素醚化衍生物止血材料 |
CN101491688A (zh) * | 2008-01-23 | 2009-07-29 | 王学洲 | 可溶性止血纱布及其制备方法 |
-
2014
- 2014-12-18 CN CN201410787569.7A patent/CN104389155B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1286329A (zh) * | 1999-08-30 | 2001-03-07 | 北京纺织科学研究所 | 一种水溶性止血纤维素纤维及其制造方法 |
CN1269376A (zh) * | 2000-03-24 | 2000-10-11 | 大连永兴医用材料有限公司 | 用纤维素材料制备可溶性防粘连材料的方法及其产品 |
CN100398159C (zh) * | 2001-04-30 | 2008-07-02 | 北京纺织科学研究所 | 水溶性纤维素醚化衍生物止血材料 |
CN101491688A (zh) * | 2008-01-23 | 2009-07-29 | 王学洲 | 可溶性止血纱布及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104389155A (zh) | 2015-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104389155B (zh) | 一种医用材料及制备方法 | |
EP2156849B1 (en) | A chitosan based fiber material, preparing method and application thereof | |
CN106478825B (zh) | 一种苎麻氧化脱胶过程中制备止血用氧化纤维素的方法 | |
CN103120802B (zh) | 可溶性止血纱布及其制备方法 | |
US7262181B2 (en) | Water soluble cellulose etherified derivatives styptic materials | |
US10875933B2 (en) | Hemostatic devices with improved properties and methods of making same | |
KR102342895B1 (ko) | 분해 가능한 지혈제 조성물 | |
WO2012136082A1 (zh) | 酰化壳聚糖伤口敷料、其制备方法及其应用 | |
Xiang et al. | A novel hydrogel based on Bletilla striata polysaccharide for rapid hemostasis: Synthesis, characterization and evaluation | |
CN106421875B (zh) | 可降解吸收的止血纤维材料及其制备方法和止血纤维制品 | |
US9555149B2 (en) | Medical material employing carboxymethyl cellulose | |
CN106620824A (zh) | 一种高效抗菌复合止血海绵的制备方法 | |
CN101623512B (zh) | 一种水溶性止血纱布的制作方法 | |
CN108785732A (zh) | 止血封堵材料及其制备方法和止血封堵制品 | |
CN103418024A (zh) | 一种新型可吸收医用材料 | |
CN103951757B (zh) | 一种医用可吸收氧化纤维素材料及其制备方法 | |
CN102886066B (zh) | 一种含钙可溶性止血材料的制备方法 | |
CN101327344A (zh) | 羧甲基壳聚糖水凝胶材料及其制法 | |
CN110644234A (zh) | 一种可吸收氧化再生纤维素材料及其制备方法与应用 | |
EP2196224A1 (en) | Absorbent material | |
CN106581738A (zh) | 一种超吸水医用复合止血海绵及其制备方法 | |
US20050031539A1 (en) | X-ray-detectable fiber and medical absorbent gauze including the same | |
CN101543639B (zh) | 一种基于天然纤维的可溶可吸收性医疗产品及其制备方法 | |
CN102471940A (zh) | 羧乙基纤维素纤维、其在伤口绷带和卫生制品中的应用及其制造方法 | |
JP2018513698A (ja) | 生体組織補強材料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Medical material and preparation method Effective date of registration: 20200609 Granted publication date: 20160224 Pledgee: Qilu Bank Co.,Ltd. Jinan Jingjie Second Branch Pledgor: SHANDONG LANTING PHARMACEUTICAL Co.,Ltd. Registration number: Y2020980002921 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210611 Granted publication date: 20160224 Pledgee: Qilu Bank Co.,Ltd. Jinan Jingjie Second Branch Pledgor: SHANDONG LANTING PHARMACEUTICAL Co.,Ltd. Registration number: Y2020980002921 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: The invention relates to a medical material and a preparation method thereof Effective date of registration: 20210625 Granted publication date: 20160224 Pledgee: Qilu Bank Co.,Ltd. Jinan Jingjie Second Branch Pledgor: SHANDONG LANTING PHARMACEUTICAL Co.,Ltd. Registration number: Y2021980005297 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220616 Granted publication date: 20160224 Pledgee: Qilu Bank Co.,Ltd. Jinan Jingjie Second Branch Pledgor: SHANDONG LANTING PHARMACEUTICAL Co.,Ltd. Registration number: Y2021980005297 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A medical material and its preparation method Effective date of registration: 20220617 Granted publication date: 20160224 Pledgee: Qilu Bank Co.,Ltd. Jinan Jingjie Second Branch Pledgor: SHANDONG LANTING PHARMACEUTICAL Co.,Ltd. Registration number: Y2022980008149 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20231108 Granted publication date: 20160224 Pledgee: Qilu Bank Co.,Ltd. Jinan Jingjie Second Branch Pledgor: SHANDONG LANTING PHARMACEUTICAL Co.,Ltd. Registration number: Y2022980008149 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A medical material and preparation method Effective date of registration: 20231115 Granted publication date: 20160224 Pledgee: Qilu Bank Co.,Ltd. Jinan Weijiazhuang Branch Pledgor: SHANDONG LANTING PHARMACEUTICAL Co.,Ltd. Registration number: Y2023980065618 |